Verici Dx plc (AIM:VRCI)
London
· Delayed Price · Currency is GBP · Price in GBX | Market Cap | 8.93M |
| Revenue (ttm) | 1.40M |
| Net Income (ttm) | -5.56M |
| Shares Out | 1.51B |
| EPS (ttm) | -0.02 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 4,280,020 |
| Average Volume | 2,076,507 |
| Open | 0.575 |
| Previous Close | 0.600 |
| Day's Range | 0.550 - 0.600 |
| 52-Week Range | 0.466 - 3.750 |
| Beta | 1.58 |
| RSI | 6.05 |
| Earnings Date | Apr 14, 2026 |
About Verici Dx
Verici Dx plc, together with its subsidiary, Verici Dx Inc, develops prognostic and diagnostic tests for kidney transplant patients in the United Kingdom and the United States. The company develops Tutivia, a post-transplant diagnostic test focused on acute cellular rejection, including sub-clinical rejection; and Protega, a liquid biopsy to predict the risk of fibrosis and long-term graft failure. It also offers sequencing services for tumor-only, tumor-normal, and germline exomes; whole transcriptome, targeted RNASeq and ncRNAs, and functiona... [Read more]
Financial Performance
In 2024, Verici Dx's revenue was $3.34 million, an increase of 229.62% compared to the previous year's $1.01 million. Losses were -$5.87 million, -32.75% less than in 2023.
Financial numbers in USD Financial StatementsNews
Half Year 2025 Verici DX PLC Earnings Call Transcript
Half Year 2025 Verici DX PLC Earnings Call Transcript
Verici Dx Plc (VRCDF) Interim Results Investor Presentation Call Transcript
Verici Dx plc - Special Call
Verici Dx plc - Special Call Company Participants Sara Barrington - CEO & Executive Director David Anderson - CFO & Company Secretary Presentation Operator Good morning, and welcome to the Verici Dx p...
AIM Market Roundup: Belluscura, Tiger Royalties, ITM Power
Belluscura, Tiger Royalties, ITM Power are today's top risers, while Catenai, Verici DX take the biggest fall on London's AIM market
AIM Market Roundup: Ethernity Networks, Verici DX, Aferian
Ethernity Networks, Verici DX, Aferian, Coro Energy and Ascent Resources are today's biggest risers and fallers on London's AIM market
AIM Market Roundup: Rome Resources, Celadon Pharmaceuticals, Churchill China
Rome Resources, Celadon Pharmaceuticals, Churchill China, Ethernity Networks and Verici DX are today's biggest movers on London's AIM market
AIM Market Roundup: Celadon Pharma, Oracle Power, Volex
Celadon Pharmaceuticals, Oracle Power, Volex, Verici DX and Slingsby are today's biggest risers and fallers on London's AIM market
FBB Biomed Signs Agreement with Verici Dx plc to Offer Research-Use-Only “RUO” Tests to Clinicians
CORALVILLE, Iowa--(BUSINESS WIRE)--FBB Biomed today announced it has signed a Master Services Agreement with Verici Dx plc (AIM: VRCI.L), for Laboratory Services for Research-Use-Only (RUO) (FDA defin...